ATRA logo

Atara Biotherapeutics, Inc. (ATRA)

Profile

Full Name

Atara Biotherapeutics, Inc.

Ticker

NASDAQ: ATRA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

October 16, 2014

Indexes

Not included

Website

https://www.atarabio.com

Employees

89

Key Details

Price

$11.82(+2.03%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$128.94M(+1404.02% YoY)

Annual EPS

-$11.41(+82.51% YoY)

PE ratio

-

Next earnings date

Nov 12, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $11.82
    ATRA price is $11.82

    30-Day Relative Volume

    0.97
    ATRA 30-day relative volume is 0.97

    Price Performance

    Price Today change

    +2.03%
    ATRA price is up +2.03% today

    Price YTD change

    -11.16%
    ATRA price is down -11.16% since January 1st

    Price 1-year change

    +50.25%
    ATRA price is up +50.25% year-on-year

    Price 3-year change

    -88.29%
    ATRA price is down -88.29% over the past 3 years

    Price Range

    Price All-time high

    $1639.00
    ATRA price is currently -99.28% below its historical high of $1639.00

    Price 3-year low

    $4.97
    ATRA price is currently +137.69% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $83.05M
    ATRA market capitalization is $83.05 million

    Market cap 3-year change

    -78.22%
    ATRA market capitalization is down -78.22% over the past 3 years

    Market cap All-time high

    $2.26B
    ATRA market capitalization is currently -96.33% below its historical high of $2.26 billion

    Market cap sector rank

    38.42%
    ATRA market capitalization is higher than 38.42% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +23.78%
    ATRA shares outstanding is up +23.78% year-on-year

    Shares Outstanding 3-Year Change

    +86.06%
    ATRA shares outstanding is up +86.06% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.31
    ATRA beta is 1.31

    200-day SMA

    $9.34
    ATRA price is currently +26.55% above its 200-day simple moving average

    50-day SMA

    $11.49
    ATRA price is currently +2.87% above its 50-day simple moving average

    RSI

    46.59
    ATRA 14-day relative strength index is 46.59

    Volume

    0.97
    ATRA 30-day relative volume is 0.97

    ATR

    $0.68
    ATRA average true range is $0.68

    10-day Historical Volatility

    40.83%
    ATRA 10-day historical volatility is 40.83%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $128.94M
    ATRA annual revenue is $128.94 million

    Revenue Analysts estimate

    $121.76M
    ATRA annual revenue is currently +5.90% higher than the consensus analysts' forecast

    Revenue 1-year change

    +1404.02%
    ATRA annual revenue is up +1404.02% year-on-year

    Revenue Sector rank

    70.3%
    ATRA annual revenue is higher than 70.3% of companies in Healthcare sector

    EPS

    EPS

    -$11.41
    ATRA annual earnings per share is -$11.41

    EPS Analysts estimate

    $2.53
    ATRA annual earnings per share is currently -550.99% lower than the consensus analysts' forecast

    EPS 1-year change

    +82.51%
    ATRA annual earnings per share is up +82.51% year-on-year

    EPS Sector rank

    12.17%
    ATRA annual earnings per share is higher than 12.17% of companies in Healthcare sector

    Profit

    Gross profit

    $107.93M
    ATRA annual gross profit is $107.93 million

    Gross margin

    83.71%
    ATRA annual gross profit margin is 83.71%

    Operating profit

    -$78.33M
    ATRA annual operating income is -$78.33 million

    Operating margin

    -60.75%
    ATRA annual operating profit margin is -60.75%

    Net income

    -$85.40M
    ATRA annual net profit is -$85.40 million

    Net margin

    -66.23%
    ATRA annual net profit margin is -66.23%

    Expenses

    Total expenses

    $214.34M
    ATRA annual total expenses is $214.34 million

    Operating expenses

    $186.26M
    ATRA annual total operating expenses is $186.26 million

    Cost of goods sold

    $21.01M
    ATRA annual cost of goods sold is $21.01 million

    Selling, general & administrative expenses

    $0.00
    ATRA annual SGA is $0.00

    Depreciation and amortization

    $5.05M
    ATRA annual depreciation & amortization is $5.05 million

    Interest expense

    $0.00
    ATRA annual interest expense is $0.00

    Income tax

    -$12.00K
    ATRA annual income tax is -$12.00 thousand

    EBIT & EBITDA

    EBIT

    -$78.33M
    ATRA annual earnings before interest & taxes is -$78.33 million

    EBITDA

    -$75.63M
    ATRA annual EBITDA is -$75.63 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $109.10M
    ATRA annual total assets is $109.10 million

    Non current assets

    $44.20M
    ATRA annual long term assets is $44.20 million

    Current assets

    $64.89M
    ATRA annual total current assets is $64.89 million

    Cash and cash equivalents

    $25.03M
    ATRA annual cash & cash equivalents is $25.03 million

    Accounts receivable

    $1.48M
    ATRA annual accounts receivable is $1.48 million

    Inventory

    $10.65M
    ATRA annual inventory is $10.65 million

    Liabilities

    Total liabilities

    $206.38M
    ATRA annual total liabilities is $206.38 million

    Long term liabilities

    $71.81M
    ATRA annual total long term liabilities is $71.81 million

    Current liabilities

    $134.57M
    ATRA annual total current liabilities is $134.57 million

    Accounts payable

    $4.37M
    ATRA annual accounts payable is $4.37 million

    Debt

    Total debt

    $84.06M
    ATRA annual total debt is $84.06 million

    Total debt 1-year change

    +45.24%
    ATRA annual total debt is up +45.24% year-on-year

    Long term debt

    $70.14M
    ATRA annual long term debt is $70.14 million

    Short term debt

    $13.92M
    ATRA annual short term debt is $13.92 million

    Equity & Capital

    Shareholders equity

    -$97.28M
    ATRA annual stockholders equity is -$97.28 million

    Book value

    -$97.28M
    ATRA annual book value is -$97.28 million

    Retained earnings

    -$2.05B
    ATRA annual retained earnings is -$2.05 billion

    Working capital

    -$69.68M
    ATRA annual working capital is -$69.68 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$68.72M
    ATRA annual cash flow from operations is -$68.72 million

    Cash from operations 1-year change

    +64.39%
    ATRA annual cash flow from operations is up +64.39% year-on-year

    Cash from investing

    $8.62M
    ATRA annual cash flow from investing activities is $8.62 million

    Cash from investing 1-year change

    -93.04%
    ATRA annual cash flow from investing activities is down -93.04% year-on-year

    Cash from financing

    $59.28M
    ATRA annual cash flow from financing activities is $59.28 million

    Cash from financing 1-year change

    +2849.35%
    ATRA annual cash flow from financing activities is up +2849.35% year-on-year

    CAPEX

    CAPEX

    $246.00K
    ATRA annual capital expenditures is $246.00 thousand

    CAPEX 1-year change

    -79.89%
    ATRA annual capital expenditures is down -79.89% year-on-year

    Free Cash Flow

    Free cash flow

    -$68.96M
    ATRA annual free cash flow is -$68.96 million

    Free cash flow 1-year change

    +64.49%
    ATRA annual free cash flow is up +64.49% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    83.71%
    ATRA annual gross profit margin is 83.71%

    Operating margin

    -60.75%
    ATRA annual operating profit margin is -60.75%

    Net margin

    -66.23%
    ATRA annual net profit margin is -66.23%

    ROA & ROE

    ROA

    -62.20%
    ATRA annual return on assets is -62.20%

    ROE

    87.79%
    ATRA annual return on equity is 87.79%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    ATRA price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    ATRA price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -2.37
    ATRA price to book ratio is -2.37

    PB ratio Sector rank

    8.16%
    ATRA price to book ratio is higher than 8.16% of companies in Healthcare sector

    PS Ratio

    PS ratio

    0.44
    ATRA price to sales ratio is 0.44

    PS ratio Sector rank

    10.77%
    ATRA price to sales ratio is higher than 10.77% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $119.18M
    ATRA enterprise value is $119.18 million

    Enterprise value Sector rank

    49.15%
    ATRA enterprise value is higher than 49.15% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    8.33
    ATRA EV/EBITDA is 8.33

    EV/EBITDA Sector rank

    79.37%
    ATRA EV/EBITDA is higher than 79.37% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    0.48
    ATRA annual current ratio is 0.48

    Quick ratio

    0.40
    ATRA annual quick ratio is 0.40

    Leverage

    Debt to equity

    -0.86
    ATRA annual debt to equity ratio is -0.86

    Interest coverage ratio

    -
    ATRA annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    6
    ATRA piotroski f-score is 6

    Altman Z-Score

    -28.08
    ATRA altman z-score is -28.08

    Analyst ratings

    Recent major analysts updates

    Mar 11, 25 Canaccord Genuity
    Buy
    Jan 22, 25 HC Wainwright & Co.
    Neutral
    Jan 17, 25 Canaccord Genuity
    Buy
    Dec 20, 24 Rodman & Renshaw
    Buy
    Nov 13, 24 Canaccord Genuity
    Buy
    Aug 21, 24 HC Wainwright & Co.
    Neutral
    Aug 16, 24 Mizuho
    Outperform
    Aug 13, 24 Canaccord Genuity
    Buy
    Jul 17, 24 Goldman Sachs
    Sell
    May 22, 24 HC Wainwright & Co.
    Neutral

    Institutional Ownership

    Screeners with ATRA included

    Growing Shares Outstanding
    US stocks
    High Piotroski score stocks
    Stocks with high beta
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    • What is the ticker symbol for Atara Biotherapeutics, Inc.?
    • Does Atara Biotherapeutics, Inc. pay dividends?
    • What sector is Atara Biotherapeutics, Inc. in?
    • What industry is Atara Biotherapeutics, Inc. in?
    • What country is Atara Biotherapeutics, Inc. based in?
    • When did Atara Biotherapeutics, Inc. go public?
    • Is Atara Biotherapeutics, Inc. in the S&P 500?
    • Is Atara Biotherapeutics, Inc. in the NASDAQ 100?
    • Is Atara Biotherapeutics, Inc. in the Dow Jones?
    • When was Atara Biotherapeutics, Inc.'s last earnings report?
    • When does Atara Biotherapeutics, Inc. report earnings?

    What is the ticker symbol for Atara Biotherapeutics, Inc.?

    The ticker symbol for Atara Biotherapeutics, Inc. is NASDAQ:ATRA

    Does Atara Biotherapeutics, Inc. pay dividends?

    No, Atara Biotherapeutics, Inc. does not pay dividends

    What sector is Atara Biotherapeutics, Inc. in?

    Atara Biotherapeutics, Inc. is in the Healthcare sector

    What industry is Atara Biotherapeutics, Inc. in?

    Atara Biotherapeutics, Inc. is in the Biotechnology industry

    What country is Atara Biotherapeutics, Inc. based in?

    Atara Biotherapeutics, Inc. is headquartered in United States

    When did Atara Biotherapeutics, Inc. go public?

    Atara Biotherapeutics, Inc.'s initial public offering (IPO) was on October 16, 2014

    Is Atara Biotherapeutics, Inc. in the S&P 500?

    No, Atara Biotherapeutics, Inc. is not included in the S&P 500 index

    Is Atara Biotherapeutics, Inc. in the NASDAQ 100?

    No, Atara Biotherapeutics, Inc. is not included in the NASDAQ 100 index

    Is Atara Biotherapeutics, Inc. in the Dow Jones?

    No, Atara Biotherapeutics, Inc. is not included in the Dow Jones index

    When was Atara Biotherapeutics, Inc.'s last earnings report?

    Atara Biotherapeutics, Inc.'s most recent earnings report was on August 11, 2025

    When does Atara Biotherapeutics, Inc. report earnings?

    The next expected earnings date for Atara Biotherapeutics, Inc. is November 12, 2025
    On this page